UC BRAID Center for Accelerated Innovation

UC BRAID 加速创新中心

• 批准号: 8743251
• 负责人: MICHAEL J PALAZZOLO
• 金额: $ 215.52万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-26 至 2020-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8743251
• 关键词: Acceleration; Accounting; Address; Adopted; Affect; American; Asthma; Atrial Fibrillation; Award; Biological Markers; Biomedical Engineering; Biomedical Research; Biopolymers; Blood Pressure; Businesses; California; Capital; Cardiac; Cardiac ablation; Cardiovascular Diseases; Cardiovascular Physiology; Cardiovascular system; Cause of Death; Cells; Cerebrovascular Disorders; Clinical; Clinical Research; Clinical Sciences; Clinical and Translational Science Awards; Collaborations; Communities; Congestive Heart Failure; Creativeness; Development; Devices; Diagnostic; Diagnostic tests; Disclosure; Ecosystem; Engineering; Ensure; Faculty; Funding; Goals; Grant; Hamman-Rich syndrome; Health; Health Sciences; Heart Diseases; Hematological Disease; Hydrogels; Implant; Incubated; Industrial Product; Industry; Intellectual Property; Investments; Joints; Knowledge; Laboratories; Legal; Legal patent; Licensing; Link; Los Angeles; Lung diseases; Mechanics; Medical; Medical Device; Mentors; Mentorship; Methods; Microscopy; Mission; Modeling; National Heart, Lung, and Blood Institute; Nonprofit Organizations; Organizational Innovation; Outcome; Pathology; Patient Care; Patients; Pharmaceutical Preparations; Positioning Attribute; Primates; Process; Productivity; Program Development; Pulmonary veins; Research; Research Infrastructure; Research Institute; Research Personnel; Resources; Retrieval; San Francisco; Staging; Structure; System; Technology; Technology Transfer; Testing; Therapeutic; Tissue Microarray; Tissues; Training and Education; Transfusion; Translating; Translational Research; Translations; United States Food and Drug Administration; United States National Institutes of Health; Universities; Ventricular; Work; base; blood product; commercialization; design; experience; fighting; hemodynamics; improved; innovation; medical schools; meetings; multidisciplinary; product development; programs; reconstruction; skills; small molecule; success; technology development; tissue repair; volunteer

The University of California Center for Accelerated Innovation proposes to create new mechanisms and to leverage its diverse strengths in diagnostics, therapeutics, and devices to support translation of promising early-stage inventions for patient benefit. The Center is a consortium of the five UC medical campuses: UC Davis, UC Irvine, UC Los Angeles, UC San Diego, and UC San Francisco. Each campus has a thriving research enterprise, nationally ranked medical school, and translational research institute funded by Clinical and Translational Science Awards (CTSA). Together, our five campuses account for nearly 7% of NHLBI's grant funding. The Center taps into the vigor and creativity of California's legendary biomedical and engineering ecosystem and integrates the many successful business, engineering and health sciences programs at our campuses. Our program will partner with well-established biomedical companies, venture capital firms, industry organizations and nonprofits focused on medical innovation. The Center is supported by UC Biomedical Research Acceleration, Integration, and Development (UC BRAID), a joint effort of the five UC biomedical campuses designed to catalyze and accelerate biomedical, clinical, and translational research across the UC system. Together we will: 1) Engage University of California heart, lung and blood disease innovators in entrepreneurism through a comprehensive education, training and mentorship program. 2) Solicit and select technologies with high commercial potential that align with NHLBI's mission and address unmet medical needs or significant scientific opportunity. 3) Incubate our most promising technologies in accordance with industry requirements to facilitate their translation to commercial products that improve patient care and enhance health. 4) Create a high-performing, sustainable infrastructure that will serve as a model to academic research centers. These programs will create an integrated, sustainable infrastructure to accelerate the translation of our NHLBI-funded discoveries to the marketplace in order to promote health and improve patient care.

加州大学加速创新中心建议建立新的机制